WO2002028362A3 - Composition vaccinale et procede de stabilisation - Google Patents
Composition vaccinale et procede de stabilisation Download PDFInfo
- Publication number
- WO2002028362A3 WO2002028362A3 PCT/FR2001/003097 FR0103097W WO0228362A3 WO 2002028362 A3 WO2002028362 A3 WO 2002028362A3 FR 0103097 W FR0103097 W FR 0103097W WO 0228362 A3 WO0228362 A3 WO 0228362A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vaccine composition
- stabilisation
- stabilisation method
- vaccine
- albumen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020037004927A KR100832551B1 (ko) | 2000-10-06 | 2001-10-08 | 백신 조성물 및 안정화 방법 |
MXPA03002875A MXPA03002875A (es) | 2000-10-06 | 2001-10-08 | Composicion de vacuna y metodo de estabilizacion. |
CA002424863A CA2424863A1 (fr) | 2000-10-06 | 2001-10-08 | Composition vaccinale et procede de stabilisation |
JP2002531988A JP2004526667A (ja) | 2000-10-06 | 2001-10-08 | ワクチン組成物および安定化方法 |
AU2001295672A AU2001295672B2 (en) | 2000-10-06 | 2001-10-08 | Vaccine composition and stabilisation method |
EP01976379A EP1357895A2 (fr) | 2000-10-06 | 2001-10-08 | Composition vaccinale et procede de stabilisation |
US10/381,948 US6982088B2 (en) | 2000-10-06 | 2001-10-08 | Vaccine composition and stabilization method using high molecular weight PVP |
NZ525117A NZ525117A (en) | 2000-10-06 | 2001-10-08 | Vaccine composition stabilised by addition of high-molecular-weight polyvinylpyrrolidone, in particular PVF360 whose molecular weight is 360 000 daltons |
BR0114350-6A BR0114350A (pt) | 2000-10-06 | 2001-10-08 | Composição vacinal e processo de estabilização da mesma no estado lìquido |
AU9567201A AU9567201A (en) | 2000-10-06 | 2001-10-08 | Vaccine composition and stabilisation method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR00/12805 | 2000-10-06 | ||
FR0012805A FR2814957B1 (fr) | 2000-10-06 | 2000-10-06 | Composition vaccinale et procede de stabilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002028362A2 WO2002028362A2 (fr) | 2002-04-11 |
WO2002028362A3 true WO2002028362A3 (fr) | 2003-09-12 |
Family
ID=8855080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2001/003097 WO2002028362A2 (fr) | 2000-10-06 | 2001-10-08 | Composition vaccinale et procede de stabilisation |
Country Status (12)
Country | Link |
---|---|
US (1) | US6982088B2 (fr) |
EP (1) | EP1357895A2 (fr) |
JP (1) | JP2004526667A (fr) |
KR (1) | KR100832551B1 (fr) |
CN (1) | CN1298387C (fr) |
AU (2) | AU9567201A (fr) |
BR (1) | BR0114350A (fr) |
CA (1) | CA2424863A1 (fr) |
FR (1) | FR2814957B1 (fr) |
MX (1) | MXPA03002875A (fr) |
NZ (1) | NZ525117A (fr) |
WO (1) | WO2002028362A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101360821A (zh) * | 2005-11-21 | 2009-02-04 | 圣诺菲·帕斯图尔有限公司 | 重组病毒的稳定制剂 |
BR112013005049A2 (pt) * | 2010-09-02 | 2016-05-31 | Sanofi Pasteur | estabilizador para a preparação de uma composição vacina da pólio seca injetável |
UA124083C2 (uk) | 2011-06-28 | 2021-07-21 | ІНГІБРЕКС, Інк. | Злитий серпіновий поліпептид і спосіб його застосування |
US10400029B2 (en) | 2011-06-28 | 2019-09-03 | Inhibrx, Lp | Serpin fusion polypeptides and methods of use thereof |
BR112013033801A2 (pt) | 2011-06-28 | 2017-12-19 | Inhibrx Llc | proteína de fusão isolada, e, método para tratar ou aliviar um sintoma de uma doença ou distúrbio inflamatórios |
CA2865551C (fr) * | 2012-03-05 | 2021-01-12 | De Staat Der Nederlanden, Vert. Door De Minister Van Vws, Ministerie Van Volksgezondheid, Welzijn En Sport | Procedes et compositions pour la stabilisation de materiels biologiques seches |
JP6426695B2 (ja) | 2013-03-14 | 2018-11-21 | タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. | 弱毒生アルファウイルス製剤のための組成物および方法 |
NL2018155B1 (en) * | 2017-01-11 | 2018-07-25 | Intervet Int Bv | Oral vaccine against ruminant respiratory disease |
US20210322542A1 (en) * | 2020-04-11 | 2021-10-21 | Qiyi Xie | Vaccination against coronavirus with poliomyelitis vaccine |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1588829A (fr) * | 1967-06-22 | 1970-03-16 | ||
US3915794A (en) * | 1973-02-09 | 1975-10-28 | Rit Rech Ind Therapeut | Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them |
US3919411A (en) * | 1972-01-31 | 1975-11-11 | Bayvet Corp | Injectable adjuvant and compositions including such adjuvant |
EP0273512A2 (fr) * | 1986-12-19 | 1988-07-06 | Duphar International Research B.V | Suspension adjuvante stabilisée comprenant du bromure de diméthyl dioctadécyl ammonium |
WO1994015636A1 (fr) * | 1993-01-08 | 1994-07-21 | Csl Limited | Preparations de vaccins |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3915764A (en) * | 1973-05-18 | 1975-10-28 | Westinghouse Electric Corp | Sputtering method for growth of thin uniform layers of epitaxial semiconductive materials doped with impurities |
US5709860A (en) * | 1991-07-25 | 1998-01-20 | Idec Pharmaceuticals Corporation | Induction of cytotoxic T-lymphocyte responses |
CA2075521C (fr) * | 1992-05-05 | 1995-11-28 | Kuniaki Koyama | Vaccin vivant stabilise |
CA2158935A1 (fr) * | 1993-10-12 | 1995-04-20 | Chiron Viagene, Inc. | Procedes de conservation de virus de recombinaison |
US6379677B1 (en) * | 2000-02-25 | 2002-04-30 | The United States Of America As Represented By The Secretary Of The Department Of Agriculture | Streptococcus iniae vaccine |
-
2000
- 2000-10-06 FR FR0012805A patent/FR2814957B1/fr not_active Expired - Fee Related
-
2001
- 2001-10-08 KR KR1020037004927A patent/KR100832551B1/ko not_active IP Right Cessation
- 2001-10-08 AU AU9567201A patent/AU9567201A/xx active Pending
- 2001-10-08 EP EP01976379A patent/EP1357895A2/fr not_active Withdrawn
- 2001-10-08 WO PCT/FR2001/003097 patent/WO2002028362A2/fr active IP Right Grant
- 2001-10-08 NZ NZ525117A patent/NZ525117A/en unknown
- 2001-10-08 MX MXPA03002875A patent/MXPA03002875A/es active IP Right Grant
- 2001-10-08 CA CA002424863A patent/CA2424863A1/fr not_active Abandoned
- 2001-10-08 US US10/381,948 patent/US6982088B2/en not_active Expired - Fee Related
- 2001-10-08 JP JP2002531988A patent/JP2004526667A/ja active Pending
- 2001-10-08 BR BR0114350-6A patent/BR0114350A/pt not_active IP Right Cessation
- 2001-10-08 AU AU2001295672A patent/AU2001295672B2/en not_active Ceased
- 2001-10-08 CN CNB018169708A patent/CN1298387C/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1588829A (fr) * | 1967-06-22 | 1970-03-16 | ||
US3919411A (en) * | 1972-01-31 | 1975-11-11 | Bayvet Corp | Injectable adjuvant and compositions including such adjuvant |
US3915794A (en) * | 1973-02-09 | 1975-10-28 | Rit Rech Ind Therapeut | Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them |
EP0273512A2 (fr) * | 1986-12-19 | 1988-07-06 | Duphar International Research B.V | Suspension adjuvante stabilisée comprenant du bromure de diméthyl dioctadécyl ammonium |
WO1994015636A1 (fr) * | 1993-01-08 | 1994-07-21 | Csl Limited | Preparations de vaccins |
Also Published As
Publication number | Publication date |
---|---|
CA2424863A1 (fr) | 2002-04-11 |
NZ525117A (en) | 2006-08-31 |
EP1357895A2 (fr) | 2003-11-05 |
WO2002028362A2 (fr) | 2002-04-11 |
KR20030096223A (ko) | 2003-12-24 |
CN1298387C (zh) | 2007-02-07 |
AU9567201A (en) | 2002-04-15 |
US6982088B2 (en) | 2006-01-03 |
AU2001295672B2 (en) | 2005-08-18 |
BR0114350A (pt) | 2004-02-17 |
FR2814957B1 (fr) | 2002-12-20 |
CN1468091A (zh) | 2004-01-14 |
US20030190331A1 (en) | 2003-10-09 |
KR100832551B1 (ko) | 2008-05-26 |
MXPA03002875A (es) | 2003-07-14 |
JP2004526667A (ja) | 2004-09-02 |
FR2814957A1 (fr) | 2002-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002009746A8 (fr) | Composition vaccinale | |
EP1245668A3 (fr) | Composition nettoyante | |
WO2002080965A3 (fr) | Composition vaccinale | |
HUP0402179A3 (en) | Poxvirus containing formulations and process for preparing stable, poxvirus containing compositions | |
IL114641A0 (en) | Pharmaceutical compositions containing fluoxetine | |
WO2002007742A3 (fr) | Bacteriophage a spectre d'activite multiple | |
WO2002028427A3 (fr) | Composition pharmaceutique pour l'immunisation contre le sida | |
GB0103169D0 (en) | Vaccine composition | |
WO2003000200A3 (fr) | ss-2'-OU 3'-HALONUCLEOSIDES | |
CA2420874A1 (fr) | Combinaisons de principes actifs a proprietes insecticides et acaricides | |
CA2241464A1 (fr) | Combinaison de nisine et de monolaurate de glycerol agissante contre helicobacter | |
EP2275124A3 (fr) | Vaccins contre le streptococcus pneumoniae à base de protéine | |
AU2001235737A1 (en) | Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same | |
WO2002048148A3 (fr) | Composes therapeutiques | |
WO2002028362A3 (fr) | Composition vaccinale et procede de stabilisation | |
MXPA02012249A (es) | Peptidos, composiciones y metodos para el tratamiento de burkholderia cepacia. | |
WO2002068335A3 (fr) | Préparation de compositions à base d'huiles essentielles pour la désinfection de liquides potables | |
WO2002070464A3 (fr) | Nouvelles hydrazones | |
AU2002217043A1 (en) | Salmonella vaccine | |
WO2003018059A3 (fr) | Preparations combinatoires de derives de propanolamine substitues par aryle avec d'autres principes actifs et leur utilisation | |
AP2004003045A0 (en) | Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same. | |
WO2000067741A3 (fr) | Methodes et compositions de formoterol (s,r) | |
WO2005011571A3 (fr) | Proteines du noyau du virus de l'hepatite utilisees comme plateformes de vaccins et leur utilisation | |
PL342624A1 (en) | Derivatives of streptogramines, method of obtaining them and compositions containing such derivatives | |
EP1238587A3 (fr) | Compositions biopesticides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10381948 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001295672 Country of ref document: AU Ref document number: PA/a/2003/002875 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 525117 Country of ref document: NZ Ref document number: 463/CHENP/2003 Country of ref document: IN Ref document number: 2003/00426 Country of ref document: TR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2424863 Country of ref document: CA Ref document number: 2002531988 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020037004927 Country of ref document: KR Ref document number: 018169708 Country of ref document: CN Ref document number: 2001976379 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWP | Wipo information: published in national office |
Ref document number: 2001976379 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020037004927 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001295672 Country of ref document: AU |